BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jankauskas SS, Kansakar U, Varzideh F, Wilson S, Mone P, Lombardi A, Gambardella J, Santulli G. Heart failure in diabetes. Metabolism 2021;125:154910. [PMID: 34627874 DOI: 10.1016/j.metabol.2021.154910] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 26.0] [Reference Citation Analysis]
Number Citing Articles
1 Demarsilis A, Reddy N, Boutari C, Filippaios A, Sternthal E, Katsiki N, Mantzoros C. Pharmacotherapy of type 2 diabetes: An update and future directions. Metabolism 2022;137:155332. [DOI: 10.1016/j.metabol.2022.155332] [Reference Citation Analysis]
2 Berezin AA, Obradovic Z, Novikov EV, Boxhammer E, Lichtenauer M, Berezin AE. Interplay between Myokine Profile and Glycemic Control in Type 2 Diabetes Mellitus Patients with Heart Failure. Diagnostics 2022;12:2940. [DOI: 10.3390/diagnostics12122940] [Reference Citation Analysis]
3 Sun J, Xu J, Liu Y, Xu X, Zhang S, Hao Y, Lin Y, Han Y, Li F, Yuan H. Proteomic and metabolomic analyses reveal the novel targets of spermine for alleviating diabetic cardiomyopathy in type II diabetic mice. Front Cardiovasc Med 2022;9:1022861. [PMID: 36312255 DOI: 10.3389/fcvm.2022.1022861] [Reference Citation Analysis]
4 Yu D, Zou M, Pan Q, Song Y, Li M, Zhang X, Zhou Y, Wang X, Guo L. Effects of liraglutide or lifestyle interventions combined with other antidiabetic drugs on abdominal fat distribution in people with obesity and type 2 diabetes mellitus evaluated by the energy spectrum ct: A prospective randomized controlled study. Front Endocrinol 2022;13:951570. [DOI: 10.3389/fendo.2022.951570] [Reference Citation Analysis]
5 Yildiz M, Lavie CJ, Morin DP, Oktay AA. The complex interplay between diabetes mellitus and atrial fibrillation. Expert Rev Cardiovasc Ther 2022. [PMID: 35984314 DOI: 10.1080/14779072.2022.2115357] [Reference Citation Analysis]
6 Djelić N, Borozan S, Dimitrijević-Srećković V, Pajović N, Mirilović M, Stopper H, Stanimirović Z. Oxidative Stress and DNA Damage in Peripheral Blood Mononuclear Cells from Normal, Obese, Prediabetic and Diabetic Persons Exposed to Thyroid Hormone In Vitro. Int J Mol Sci 2022;23:9072. [PMID: 36012352 DOI: 10.3390/ijms23169072] [Reference Citation Analysis]
7 Djuricic I, Calder PC. Polyunsaturated fatty acids and metabolic health: novel insights. Curr Opin Clin Nutr Metab Care 2022. [PMID: 35943130 DOI: 10.1097/MCO.0000000000000865] [Reference Citation Analysis]
8 Jankauskas S, Kansakar U, De Donato A, Mone P, Varzideh F, Santulli G. Parkin Controls Cardiac Function in Obesity by Regulating Mitochondrial Calcium Uptake. JACC Basic Transl Sci 2022;7:797-9. [PMID: 36061335 DOI: 10.1016/j.jacbts.2022.04.015] [Reference Citation Analysis]
9 Berezin AA, Fushtey IM, Berezin AE. The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure. Biomedicines 2022;10:1751. [DOI: 10.3390/biomedicines10071751] [Reference Citation Analysis]
10 Höskuldsdóttir G, Franzén S, Eeg-Olofsson K, Eliasson B. Risk trajectories of complications in over one thousand newly diagnosed individuals with type 2 diabetes. Sci Rep 2022;12:11784. [PMID: 35821071 DOI: 10.1038/s41598-022-16135-0] [Reference Citation Analysis]
11 Gao Y, Liu W, Su X, Li X, Yu F, Zhang N, Huang Y. The Beneficial Effects of Chinese Herbal Monomers on Ameliorating Diabetic Cardiomyopathy via Nrf2 Signaling. Oxidative Medicine and Cellular Longevity 2022;2022:1-15. [DOI: 10.1155/2022/3959390] [Reference Citation Analysis]
12 Rosa CM, Campos DHS, Reyes DRA, Damatto FC, Kurosaki LY, Pagan LU, Gomes MJ, Corrêa CR, Fernandes AAH, Okoshi MP, Okoshi K. Effects of the SGLT2 Inhibition on Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats, a Model of Type 1 Diabetes Mellitus. Antioxidants 2022;11:982. [DOI: 10.3390/antiox11050982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Paolisso P, Bergamaschi L, Santulli G, Gallinoro E, Cesaro A, Gragnano F, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Casella G, Mauro C, Vassilev D, Marfella R, Calabrò P, Barbato E, Pizzi C. Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry. Cardiovasc Diabetol 2022;21:77. [PMID: 35570280 DOI: 10.1186/s12933-022-01506-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 20.0] [Reference Citation Analysis]
14 Jordhani M, Seiti J, Barrios V. Clinical and echocardiographic characteristics in patients with heart failure and type 2 diabetes. Future Cardiol 2022. [PMID: 35506465 DOI: 10.2217/fca-2022-0006] [Reference Citation Analysis]
15 Pansini A, Lombardi A, Morgante M, Frullone S, Marro A, Rizzo M, Martinelli G, Boccalone E, De Luca A, Santulli G, Mone P. Hyperglycemia and Physical Impairment in Frail Hypertensive Older Adults. Front Endocrinol 2022;13:831556. [DOI: 10.3389/fendo.2022.831556] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Hu S, Yang M, Huang S, Zhong S, Zhang Q, Ding H, Xiong X, Hu Z, Yang Y. Different Roles of Resident and Non-resident Macrophages in Cardiac Fibrosis. Front Cardiovasc Med 2022;9:818188. [PMID: 35330948 DOI: 10.3389/fcvm.2022.818188] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Mone P, Varzideh F, Kansakar U, Infante C, Lombardi A, de Donato A, Frullone S, Santulli G. Omega-3 fatty acids coordinate glucose and lipid metabolism in diabetic patients. Lipids Health Dis 2022;21:31. [PMID: 35337345 DOI: 10.1186/s12944-022-01642-w] [Reference Citation Analysis]
18 Le S, Zhang Y, Voutilainen A, Tan X, Laukkanen J, Wang C, Cheng S. Differences in cardiometabolic risk profiles between Chinese and Finnish older adults with glucose impairment and central obesity. J Endocrinol Invest 2022. [PMID: 35325446 DOI: 10.1007/s40618-022-01777-8] [Reference Citation Analysis]
19 Dridi H, Santulli G, Gambardella J, Jankauskas SS, Yuan Q, Yang J, Reiken S, Wang X, Wronska A, Liu X, Lacampagne A, Marks AR. IP3 receptor orchestrates maladaptive vascular responses in heart failure. J Clin Invest 2022;132:e152859. [PMID: 35166236 DOI: 10.1172/JCI152859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Wilson S, Mone P, Kansakar U, Jankauskas SS, Donkor K, Adebayo A, Varzideh F, Eacobacci M, Gambardella J, Lombardi A, Santulli G. Diabetes and restenosis. Cardiovasc Diabetol 2022;21:23. [PMID: 35164744 DOI: 10.1186/s12933-022-01460-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
21 Miljković T, Ilić A, Milovančev A, Bjelobrk M, Stefanović M, Stojšić-milosavljević A, Tadić S, Golubović M, Popov T, Petrović M. Left Atrial Strain as a Predictor of Left Ventricular Diastolic Dysfunction in Patients with Arterial Hypertension. Medicina 2022;58:156. [DOI: 10.3390/medicina58020156] [Reference Citation Analysis]
22 Jankauskas SS, Gambardella J, Kansakar U, Wilson S, Mone P, Varzideh F, Donkor K, Eacobacci M, Adebayo A, Morelli M, Ferrara J, Wang X, Lombardi A, Santulli G. MicroRNAs and diabetes mellitus. MicroRNA 2022. [DOI: 10.1016/b978-0-323-89774-7.00001-7] [Reference Citation Analysis]
23 Sun Y, Ding S. NLRP3 Inflammasome in Diabetic Cardiomyopathy and Exercise Intervention. Int J Mol Sci 2021;22:13228. [PMID: 34948026 DOI: 10.3390/ijms222413228] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
24 Mone P, Morgante M, Pansini A, Jankauskas SS, Rizzo M, Lombardi A, Frullone S, Santulli G. Effects of insulin resistance on mitochondrial (dys)function. Atherosclerosis 2021:S0021-9150(21)01465-9. [PMID: 34903382 DOI: 10.1016/j.atherosclerosis.2021.11.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]